Segment Information (Tables)

3 Months Ended

Mar. 31, 2014

Segment Information

Schedule of revenues, cost of revenues and gross profit for each commercial product

Revenues, cost of revenues and gross profit for each of our commercial products were as follows (in thousands):

	Three Months Ended March 31,
	Remodulin		Tyvaso		Adcirca		Total
2014
Revenues	$	136,106	$	107,086	$	41,361	$	284,553
Cost of revenues	13,226		14,454		2,593		30,273
Gross profit	$	122,880	$	92,632	$	38,768	$	254,280
2013
Revenues	$	114,681	$	94,645	$	33,820	$	243,146
Cost of revenues	13,406		13,783		2,124		29,313
Gross profit	$	101,275	$	80,862	$	31,696	$	213,833